Second Xiangya Hospital of Central South University
Phase
Observational
Started
2022-05-20
Last updated
2022-10-25
Condition(s) studied
Diabetes Mellitus, Type 1
Investigational drug(s) / intervention(s)
HLA
HLA: Distinguish based on clinical features
Study summary
This study took FT1D(fulminant type 1 diabetes) as the research object, collected the cases of FT1D patients, and described the clinical characteristics of this type of disease. The HLA susceptibility genes of FT1D were identified by PCR and other techniques, taking age-sex-matched healthy subjects as controls and HLA genes as the research entry point.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
patients with fulminant 1 diabetes
Inclusion Criteria:
1\) diabetic ketosis or ketoacidosis occurred soon after the onset of hyperglycemic symptoms; 2) patient presented with plasma glucose ≥16.0 mmol/L and HbA1c \<8.7% at the first visit; and 3) patient had urinary C-peptide excretion \<10 µg/day,fasting serum C-peptide level \<0.10 nmol/L, or postprandial serum C-peptide \<0.17 nmol/L at onset
Exclusion Criteria:
Case reports of previously diagnosed with diabetes were excluded.
Healthy Volunteers
Inclusion Criteria:
* Normal control: The inclusion criteria are as follows: (1) Oral glucose tolerance test (OGTT): fasting blood glucose (FPG) \<5.6 mmol/L and postprandial 2 h blood glucose (PPG) \<7.8 mmol/L. The participants voluntarily signed the informed consent and extracted 3ml of peripheral blood for DNA extraction.
Exclusion Criteria:
* The exclusion criteria were as follows: (1) with heart, brain, liver, kidney or other chronic diseases; (2) with other types of autoimmune diseases; (3) with malignant tumors; (4) with a family history of diabetes.
Primary outcome measure(s)
Change in serum hemoglobin A1c level — Every year for up to 5 years A1c reflects the average blood glucose level
Trial sites (10)
Facility
City
Region
Status
Quanzhou First People's Hospital
Quanzhou
Fujian
Recruiting
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou
Guangdong
Recruiting
The First Affiliated Hospital of Guangxi Medical University
Nanning
Guangxi
Recruiting
Guizhou Provincial People's Hospital
Zunyi
Guangzhou
Recruiting
Hainan Provincial People's Hospital
Haikou
Hainan
Recruiting
Changsha Central Hospital
Changsha
Hunan
Recruiting
Yancheng Third People's Hospital
Yancheng
Jiangs
Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang
Jiangxi
Recruiting
Yunnan Provincial People's Hospital
Kunming
Yunnan
Recruiting
The Second Xiangya Hospital of Central South University
Changsha
China
Recruiting
More Second Xiangya Hospital of Central South University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.